Precision Peptide Company raises C$1.3M from warrants to boost peptide product development and distribution.

The Precision Peptide Company secured approximately C$1.3 million by exercising outstanding warrants, strengthening its financial position. The funds will support the expansion of its Amino Innovations platform, focusing on advanced peptide delivery systems like transdermal and oral patches. This development aims to overcome delivery challenges in the peptide wellness market and expand distribution across North America. The company is positioned to benefit from evolving regulatory clarity favoring scientifically backed peptide products.